CureFit had held discussions with SoftBank Vision Fund over a $200m investment, but Unilever Ventures has instead stepped up as part of a $120m round.

India-based healthcare and wellness services provider CureFit has closed a $120m funding round that featured Unilever Ventures, the corporate venturing arm of consumer goods conglomerate Unilever, the Economic Times reported yesterday. Financial services firm Kotak Mahindra Bank also took part in the round, as did Epiq Capital, Innoven Capital, Accel Partners, Kalaari Capital, Oaktree Capital…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.